Literature DB >> 11703290

beta-Catenin expression in the transitional cell zone of pilomatricoma.

S W Park1, K S Suh, H Y Wang, S T Kim, H S Sung.   

Abstract

BACKGROUND: beta-Catenin, a participant in the Wnt pathway, has been shown to play an important role in the morphogenesis of hair follicles and the formation of hair follicle-related tumours, including pilomatricomas. It has been observed that at least 75% of human pilomatricomas possess activating mutations in beta-catenin. These findings suggested that beta-catenin plays an important role in the tumorigenesis of pilomatricomas. However, the pattern of beta-catenin expression in pilomatricoma tissues is still unclear. Objectives To examine the expression of beta-catenin in human pilomatricomas by immunohistochemical staining.
METHODS: Twenty-six formalin-fixed and paraffin-embedded samples of pilomatricoma tissue were studied.
RESULTS: Most transitional cells of pilomatricoma expressed beta-catenin strongly, but the basophilic cells and shadow cells did not. beta-Catenin showed a prominent membranous immunoreactivity and a small amount of condensed cytoplasmic staining, but there was definitely no evidence of nuclear positivity.
CONCLUSIONS: These findings imply that beta-catenin is primarily involved in cell-cell adhesion rather than cellular proliferation during pilomatricoma pathogenesis, and suggest that if beta-catenin is involved in pilomatricoma tumorigenesis and tumour growth, it plays an indirect role.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703290     DOI: 10.1046/j.1365-2133.2001.04433.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.

Authors:  Athamassios Kotsinas; Konstantinos Evangelou; Panayotis Zacharatos; Christos Kittas; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  The Immunohistochemical Patterns of the beta-Catenin Expression in Pilomatricoma.

Authors:  Young Sik Kim; Dong Hoon Shin; Jong Soo Choi; Ki-Hong Kim
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

3.  Cell-cell adhesion proteins in melanocytic pilomatrix carcinoma.

Authors:  Alejandro Peralta Soler; Susan E Kindel; Gayle McCloskey; James L Burchette
Journal:  Rare Tumors       Date:  2010-09-30

4.  Giant pilomatricoma in a patient with tuberous sclerosis, both diagnosed in the adult life.

Authors:  Cristina Isabel Pinho Resende; Joana Gomes; Maria da Luz Duarte; Celeste Brito
Journal:  BMJ Case Rep       Date:  2013-08-29

Review 5.  Picture of the month. Eyelid pilomatricoma.

Authors:  Leslie Castelo-Soccio; William R Katowitz; James A Katowitz; Kara N Shah; James R Treat; Albert C Yan
Journal:  Arch Pediatr Adolesc Med       Date:  2009-10

6.  Rapidly growing pilomatrixoma on eyebrow.

Authors:  Sunil Kumar
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

7.  No Evidence of Abnormal Expression of Beta-Catenin and Bcl-2 Proteins in Pilomatricoma as One Clinical Feature of Tetrasomy 9p Syndrome.

Authors:  Chariyawan Charalsawadi; Sasipong Trongnit; Kanoot Jaruthamsophon; Juthamas Wirojanan; Somchit Jaruratanasirikul; Anupong Nitiruangjaras; Pornprot Limprasert
Journal:  Int J Pediatr       Date:  2021-12-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.